Jefferies Highlights Three Biotech Stocks With Blockbuster Potential
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake damages buildings, disrupts power and air travel
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
3 high-conviction SMID-cap biotech stocks to buy: Jefferies
October 1, 2026 3:00 PM EDTJefferies named the stocks it sees as high-conviction small- and mid-cap biotech ideas in a new note to clients.
The stocks in question are Definium Therapeutics (NASDAQ: DFTX), Axsome Therapeutics (NASDAQ: AXSM), and BridgeBio Pharma (NASDAQ: BBIO).
Analyst Andrew Tsai said a tougher macro... More



